Can-Fite BioPharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	6.45	4.83	4.28	2.98	4.39	8.27
Short-Term Investments	0	3.06	4.64	5	14.51	-
Trading Asset Securities	-	-	-	0.01	0.24	0.08
Cash & Short-Term Investments	6.46	7.89	8.92	7.99	19.14	8.34
Cash Growth	36.55%	-11.60%	11.71%	-58.27%	129.40%	202.17%
Prepaid Expenses	1.17	1.02	0.91	1.12	0.88	1.04
Other Current Assets	-	0.08	0.08	0.05	0.05	0.02
Total Current Assets	7.62	8.98	9.91	9.16	20.07	9.4
Property, Plant & Equipment	0.1	0.14	0.08	0.13	0.19	0.12
Total Assets	7.72	9.12	9.99	9.28	20.25	9.52
Accounts Payable	1.15	0.62	0.43	0.9	0.95	0.56
Accrued Expenses	0.51	0.98	0.94	0.78	0.91	0.33
Current Portion of Leases	0.06	0.05	0.03	0.05	0.05	0.04
Current Unearned Revenue	0.41	0.41	0.62	0.78	0.82	0.33
Total Current Liabilities	2.12	2.05	2.02	2.5	2.73	1.27
Long-Term Leases	0.03	0.05	0.01	0.01	0.07	0.02
Long-Term Unearned Revenue	1.38	1.58	1.71	2.3	3.07	2.16
Total Liabilities	3.54	3.68	3.75	4.81	5.87	3.45
Common Stock	-	-	-	-	-	33.04
Additional Paid-In Capital	174.29	170.67	163.6	154.19	153.93	97.38
Retained Earnings	-171.24	-166.36	-158.48	-150.85	-140.67	-125.47
Comprehensive Income & Other	1.13	1.13	1.13	1.13	1.13	1.13
Total Common Equity	4.18	5.44	6.24	4.47	14.38	6.07
Shareholders' Equity	4.18	5.44	6.24	4.47	14.38	6.07
Total Liabilities & Equity	7.72	9.12	9.99	9.28	20.25	9.52
Total Debt	0.09	0.1	0.04	0.06	0.12	0.07
Net Cash (Debt)	6.37	7.78	8.88	7.93	19.02	8.28
Net Cash Growth	36.29%	-12.37%	12.08%	-58.32%	129.76%	208.12%
Net Cash Per Share	6.43	10.73	20.84	29.15	103.14	69.27
Filing Date Shares Outstanding	1.32	1.04	0.5	0.41	0.27	0.17
Total Common Shares Outstanding	1.32	0.99	0.45	0.27	0.27	0.15
Working Capital	5.5	6.93	7.89	6.66	17.34	8.13
Book Value Per Share	3.16	5.47	13.77	16.45	52.89	39.29
Tangible Book Value	4.18	5.44	6.24	4.47	14.38	6.07
Tangible Book Value Per Share	3.16	5.47	13.77	16.45	52.89	39.29
Machinery	-	0.08	0.28	0.28	0.27	0.26
Leasehold Improvements	-	-	0.01	0.01	0.01	0.01

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.